Transfusion and Apheresis Science
Volume 28, Issue 1 , Pages 3-7 , February 2003

Effects of replacement fluids on coagulation system used for therapeutic plasma exchange

  • Ibrahim Tek

      Affiliations

    • Ibni Sina Hospital, Hemapheresis Unit and Blood Bank, Department of Hematology, Medical School, Ankara University, Sıhhıye, 06100 Ankara, Turkey
    • ,
  • Önder Arslan

      Affiliations

    • Ibni Sina Hospital, Hemapheresis Unit and Blood Bank, Department of Hematology, Medical School, Ankara University, Sıhhıye, 06100 Ankara, Turkey
    • Corresponding Author InformationCorresponding author
    • ,
  • Mutlu Arat

      Affiliations

    • Ibni Sina Hospital, Hemapheresis Unit and Blood Bank, Department of Hematology, Medical School, Ankara University, Sıhhıye, 06100 Ankara, Turkey
    • ,
  • Muhit Özcan

      Affiliations

    • Ibni Sina Hospital, Hemapheresis Unit and Blood Bank, Department of Hematology, Medical School, Ankara University, Sıhhıye, 06100 Ankara, Turkey
    • ,
  • Beyza Akdağ

      Affiliations

    • Faculty of Medicine, Department of Biostatistics, Hacettepe University, Sıhhıye, Ankara, Turkey
    • ,
  • Osman İlhan

      Affiliations

    • Ibni Sina Hospital, Hemapheresis Unit and Blood Bank, Department of Hematology, Medical School, Ankara University, Sıhhıye, 06100 Ankara, Turkey

Received 22 July 2002 ,Accepted 4 August 2002.

References 

  1. Norda R, Berseus O, Stegmayr B. Advers events and problems in therapeutic hemapheresis. A report from the Swedish registry. Transfus Apheresis Sci. 2001;25:33–41
  2. Le Conte P, Nicolas F. Replacement fluids in plasmapheresis: cross-over comparative study. Intensive Care Med. 1997;23:34
  3. Reimann PM, Mason PD. Plasmapheresis: technique and complication. Intensive Care Med. 1990;337:395–397
  4. Domen RE, Kennedy MS. Hemostatic imbalances produced by plasma exchange. Transfusion. 1984;24:336–339
  5. Stump DC, Strauss RG. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion. 1985;25:349–354
  6. Misher JM. Pharmacology of hydroxyethyl satrch. Oxford: Oxford Universty Press; 1982;
  7. Strauss RG, Koepke JA. Clinical and laboratory effects on donors of intermittent-flow centrifugation, platelet-leukopheresisi performed with hydroxyethyl starch and citrate. Clin Lab Haematol. 1980;2:1–11
  8. Weinstein R. Basic principles of therapeutic blood exchange Apheresis: principles and practice. Bethesda, MD: AABB press; 1997; p. 272–75
  9. Keller AJ, Chrinside A. Coagulation abnormalities produced by plasma exchange on the cell separator with special reference to fibrinogen and platelet levels. Br J Haematol. 1979;42:593–603
  10. Berkman EM, Orlin JB. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion. 1980;56:171–178
  11. Wood L, Jacobs P. The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunglobulin, and complement levels. J Clin Apheresis. 1986;3:124–128
  12. Domen RE. Hemostatic imbalances produced by plasma exchange. Transfusion. 1984;24:336–339
  13. Sutton DM, Nair RC. Complications of plasma exchange. Transfusion. 1989;29:124–127
  14. Arslan, Ö, Tombuloğlu M, Karadoğan I, Kılıç B, Çetin M, Başlamış F, et al. National Survey of Total Plasma Exchange In Turkey, 1998. ASFA’s 21st Annual Meeting Final Programme, 6–8 April 2000, Las Vegas, Nevada
  15. Arslan Ö, Arat M, ılhan O. Therapeutic plasma exchange and clinical application, definition and the history. Turkish J Hematol, in press

PII: S1473-0502(02)00093-9

doi: 10.1016/S1473-0502(02)00093-9

Transfusion and Apheresis Science
Volume 28, Issue 1 , Pages 3-7 , February 2003

Article Tools

* Image Usage & Resolution